What's in Fakultas Kedokteran Universitas Indonesia's pipeline?

Fakultas Kedokteran Universitas Indonesia has 7 drugs in our index: 4 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Fakultas Kedokteran Universitas Indonesia's portfolio?

Top competitors by shared drug class: Aesculape CRO Belgium BV, AmDerma, Astellas Pharma Inc, Bausch Health Americas, Inc., Bayer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/fakultas-kedokteran-universitas-indonesia.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Fakultas Kedokteran Universitas Indonesia — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fakultas Kedokteran Universitas Indonesia pipeline: 4 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 2 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Placebo Shampoo	Placebo Shampoo	marketed			Dermatology
PCV Vaccine	PCV Vaccine	marketed
Ketoconazole 2% Shampoo	Ketoconazole 2% Shampoo	marketed	Imidazole antifungal	Fungal cytochrome P450 (CYP51 / lanosterol 14α-demethylase)	Dermatology
PPV Vaccine	PPV Vaccine	marketed	Polysaccharide vaccine	Streptococcus pneumoniae capsular polysaccharides	Immunology / Infectious Disease
IgM-enriched IVIG	IgM-enriched IVIG	phase 3	Immunoglobulin preparation	Fc receptors, complement system, pathogen-specific antigens	Immunology
Cocos Nucifera Whole	Cocos Nucifera Whole	phase 3			Nutritional/Metabolic Health

Therapeutic area mix

Dermatology · 2
Immunology · 1
Immunology / Infectious Disease · 1
Nutritional/Metabolic Health · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Aesculape CRO Belgium BV · 1 shared drug class
AmDerma · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
Bausch Health Americas, Inc. · 1 shared drug class
Bayer · 1 shared drug class
Celgene · 1 shared drug class
Galderma R&D · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Fakultas Kedokteran Universitas Indonesia:

Cite this brief

Drug Landscape (2026). Fakultas Kedokteran Universitas Indonesia — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/fakultas-kedokteran-universitas-indonesia. Accessed 2026-05-17.